Kevin S. Roof

909 total citations
27 papers, 581 citations indexed

About

Kevin S. Roof is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Kevin S. Roof has authored 27 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 10 papers in Surgery and 7 papers in Oncology. Recurrent topics in Kevin S. Roof's work include Gastric Cancer Management and Outcomes (9 papers), Esophageal Cancer Research and Treatment (8 papers) and Lung Cancer Treatments and Mutations (8 papers). Kevin S. Roof is often cited by papers focused on Gastric Cancer Management and Outcomes (9 papers), Esophageal Cancer Research and Treatment (8 papers) and Lung Cancer Treatments and Mutations (8 papers). Kevin S. Roof collaborates with scholars based in United States and Canada. Kevin S. Roof's co-authors include Elizabeth A. Reap, Philip L. Cohen, Jessica K. Booker, Michelle Borrero, Noah C. Choi, Thomas J. Lynch, Panos Fidias, Christopher H. Crane, Adam Raben and Mohan Suntharalingam and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer.

In The Last Decade

Kevin S. Roof

27 papers receiving 574 citations

Peers

Countries citing papers authored by Kevin S. Roof

Since Specialization

Citations

This map shows the geographic impact of Kevin S. Roof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin S. Roof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin S. Roof more than expected).

Fields of papers citing papers by Kevin S. Roof

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin S. Roof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin S. Roof. The network helps show where Kevin S. Roof may publish in the future.

Co-authorship network of co-authors of Kevin S. Roof

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin S. Roof. A scholar is included among the top collaborators of Kevin S. Roof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin S. Roof. Kevin S. Roof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Decipher score as a predictor of response to treatment intensification in the NRG Oncology-RTOG 0534 (SPPORT) phase III randomized post-prostatectomy salvage radiotherapy trial.	Journal of Clinical Oncology	Alan Pollack, Marla Johnson et al.	2
2	Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848	International Journal of Radiation OncologyBiologyPhysics	Leila T. Tchelebi, Kathryn Winter et al.	6
3	Virtual On-Treatment Visits: Implementation, Patient Perspectives, Barriers, Limitations, Benefits, and Opportunities	Advances in Radiation Oncology	Kevin S. Roof, J.M. Butler et al.	3
4	Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes	Neurosurgery	William A. Hall, Stephanie L. Pugh et al.	7
5	Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01	Urologic Oncology Seminars and Original Investigations	Raymond H. Mak, Daniel Hunt et al.	14
6	Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811	International Journal of Radiation OncologyBiologyPhysics	Corinne Doll, Jennifer Moughan et al.	9
7	A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy–Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012	International Journal of Radiation OncologyBiologyPhysics	Shannon Fogh, Snehal Deshmukh et al.	32
8	Rtog 0436: A Phase III Trial of Cisplatin, Paclitaxel and Radiation with or Without Cetuximab in the Nonoperative Treatment of Esophageal Cancer	Annals of Oncology	David H. Ilson, Kathryn Winter et al.	1
9	The initial report of RTOG 0436: A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery.	Journal of Clinical Oncology	Mohan Suntharalingam, Kathryn Winter et al.	17
10	Adjuvant radiation, androgen deprivation, and docetaxel for high-risk prostate cancer post-prostatectomy: Results of RTOG 0621.	Journal of Clinical Oncology	Mark Hurwitz, Oliver Sartor et al.	2
11	The Significance of p16 and p53 Expression on Clinical Outcome in Patients with Anal Cancer Treated with Chemoradiation Therapy: An Analysis of RTOG 98-11	International Journal of Radiation OncologyBiologyPhysics	Corinne Doll, Kathryn Winter et al.	1
12	RTOG 0436: A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery.	Journal of Clinical Oncology	David H. Ilson, Jennifer Moughan et al.	17
13	DNA Repair Biomarkers Predict Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer	International Journal of Radiation OncologyBiologyPhysics	Brian M. Alexander, Andrzej Niemierko et al.	38
14	Concurrent cisplatin, 5-FU, paclitaxel, and radiation therapy in patients with locally advanced esophageal cancer	International Journal of Radiation OncologyBiologyPhysics	Kevin S. Roof, John J. Coen et al.	27
15	A three-dimensional ct based analysis of inter-fraction bladder motion during radiotherapeutic treatment of bladder cancer	International Journal of Radiation OncologyBiologyPhysics	Kevin S. Roof, A. Mazal et al.	1
16	Neo-adjuvant radiation, cisplatin, 5-FU +/− paclitaxel in locally advanced esophageal cancer	Journal of Clinical Oncology	Kevin S. Roof, John J. Coen et al.	5
17	Radiation dose escalation in limited-stage small-cell lung cancer	International Journal of Radiation OncologyBiologyPhysics	Kevin S. Roof, Panos Fidias et al.	49
18	Radiation Dose Intensification in Limited-Stage Small-Cell Lung Cancer	Clinical Lung Cancer	Kevin S. Roof, Panos Fidias et al.	2
19	Markedly Diminished Radiation‐induced Lymphocyte Apoptosis in lpr Mice Suggests a Role for Fas in Eliminating Damaged Cells	Annals of the New York Academy of Sciences	Elizabeth A. Reap, Kevin S. Roof et al.	4
20	Radiation and stress-induced apoptosis: A role for Fas/Fas ligand interactions	Proceedings of the National Academy of Sciences	Elizabeth A. Reap, Kevin S. Roof et al.	152

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact